Evaluation of DEMU La' farrerr Topical Cream Effect on Bruises Caused by Filler Injectio
Phase 3
Recruiting
- Conditions
- Bruising Caused by Nasolabial Filler Injection.Spontaneous ecchymoses (Petechiae). Excl: ecchymoses in fetus and newborn, purpura.R23.3
- Registration Number
- IRCT20141209020250N7
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Individuals Receiving Nasolabial Filler Injection or Facial Botox at Razi Hospital (With Bruises Caused by Filler Injection in the Face Area)
Age between 18 and 65
Exclusion Criteria
Pregnancy
Possibility or Having Plan for Pregnancy in the Next 3 Months
Lactation
Taking Aspirin and Other Anticoagulant Medicines
Unwillingness to Participating in the Trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bruise Intensity by the Surface Area. Timepoint: Days 1, 2, 3, 4, 5, 7, 10 and 14. Method of measurement: Total bruised area measurement.;The stage (age) of bruises. Timepoint: Days 1, 2, 3, 4, 5, 7, 10 and 14. Method of measurement: Spot Color by Colorimetric Scale NNDV No. 2.;Bruise Control Time Period. Timepoint: Length of treatment period (14 days). Method of measurement: Clinical examination and review of images taken from the position.
- Secondary Outcome Measures
Name Time Method Pain feeling in the spot. Timepoint: Days 1, 2, 3, 4, 5, 7, 10 and 14. Method of measurement: The numeric rating scale (NRS).;Side Effects (Hypersensitivity or any other side effects not related to other treatments and medicines received by the patient). Timepoint: Length of treatment period (14 days). Method of measurement: Patient statements during examinations and other times.;Volume of filler injected to the site by ml. Timepoint: Day 0 (Filler injection). Method of measurement: ml of filler injected.